Benzinga Pro data, Milestone Scientific (AMEX:MLSS) reported Q2 sales of $1.65 million. Earnings fell to a loss of $2.88 million, resulting in a 50.13% decrease from last quarter.
ROSELAND, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.04) per share. This is unchanged from the same period last year. The company reported quarterly sales of $1.65 million which missed the analyst consensus
Milestone Scientific (AMEX:MLSS) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Milestone Scientific reported in-line EPS of $-0.03 versus an estimate of $-0.03.
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Gainers
Mullen Automotive, Inc. (NASDAQ: MULN) shares rose 16.2% to $2.51 in pre-market trading. Mullen Automotive announced plans to begin construction for EV battery pack production at high voltage R&D facility in Monrovia, California.
According to Benzinga Pro data, during Q4, Milestone Scientific (AMEX:MLSS) posted sales of $2.85 million. Earnings were up 44.62%, but Milestone Scientific still reported an overall loss of $1.14 million.